Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
New EVA Application
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
Publ. Version/Full Text
DOI
PMC
 |
Closed |
Open Access Green as soon as Postprint is submitted to ZB.
Considering personalized Interferon-β therapy for COVID-19.
Antimicrob. Agents Chemother. 65:e00065-21 (2021)
Davoudi-Monfared et al. (1) report in this Journal the results from a clinical trial on COVID-19 patients showing that subcutaneous administration of interferon-β (IFN-β) was associated with a more rapid recovery from SARS-CoV-2 infection and decreased mortality.….
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
5.191
0.000
3
9
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Biotherapy ; Covid-19 ; Interferon Beta
Language
english
Publication Year
2021
HGF-reported in Year
2021
ISSN (print) / ISBN
0066-4804
e-ISSN
1098-6596
Quellenangaben
Volume: 65,
Issue: 4,
Article Number: e00065-21
Publisher
American Society for Microbiology (ASM)
Publishing Place
1752 N St Nw, Washington, Dc 20036-2904 Usa
Reviewing status
Peer reviewed
Institute(s)
Institute of Environmental Medicine (IEM)
POF-Topic(s)
30202 - Environmental Health
Research field(s)
Allergy
PSP Element(s)
G-503400-001
WOS ID
WOS:000630326800021
Scopus ID
85103013500
PubMed ID
33558300
Erfassungsdatum
2021-04-19